European Multi-Centre Post-Market Registry on Thoracic Endovascular Arch Repair Using Castor™ and Cratos™
Recruiting
Observational Study
Dissection of Thoracic Aorta
Dissection of Thoracic Descending Aorta
Aneurysm of Aorta, Thoracic
Penetrating Aortic Ulcers (PAUs)
Intramural Hematoma of the Thoracic Aorta
Ulcer-like Projection (ULP)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 100 (estimated)
- Sponsor
- Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The Castor™ and Cratos™ Branched Aortic Stent Graft Systems are medical devices designed for the minimally invasive endovascular treatment of thoracic aortic pathologies in the descending aorta. The goal of this multi-centre retrospective and prospective observational registry study is to capture the short-, medium- to long-term safety and performance data of how Castor™ and Cratos™ stent-grafts w…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Implantation of a Castor™ or Cratos™ single branch endoprothesis with incorporation of the left subclavian artery
* Age \>18 years
Exclusion Criteria:
* Patients allergic to the materials of the device;
* Patients with severe or potentially systemic infections that increase …
Contacts